Mirum Pharmaceuticals, Inc. (FRA:08D)

Mirum Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	3,847	1,917	1,245	672	428	418
Market Cap Growth	99.64%	54.01%	85.16%	57.27%	2.40%	-15.33%
Enterprise Value	3,798	1,949	1,247	501	263	311
Last Close Price	66.50	39.20	27.60	17.80	13.63	-
PS Ratio	9.57	5.89	7.38	9.32	25.41	-
PB Ratio	15.45	8.80	5.53	5.06	4.04	2.97
P/TBV Ratio	75.03	-	-	8.65	4.79	2.97
P/FCF Ratio	101.83	212.71	-	-	-	-
P/OCF Ratio	100.98	192.25	-	-	-	-
EV/Sales Ratio	9.36	5.99	7.39	6.95	15.62	-
EV/FCF Ratio	100.54	216.27	-	-	-	-
Debt / Equity Ratio	1.09	1.41	1.24	0.02	0.02	0.02
Debt / FCF Ratio	7.19	34.05	-	-	-	-
Asset Turnover	0.65	0.51	0.37	0.24	0.07	-
Inventory Turnover	4.16	3.65	3.38	3.50	-	-
Quick Ratio	3.01	2.83	4.07	2.72	3.76	12.56
Current Ratio	3.31	3.10	4.45	2.94	3.91	12.80
Return on Equity (ROE)	-15.81%	-37.08%	-83.65%	-103.46%	-57.47%	-68.29%
Return on Assets (ROA)	-3.60%	-8.31%	-13.65%	-25.33%	-40.48%	-33.64%
Return on Capital (ROIC)	-4.50%	-9.95%	-19.46%	-61.42%	-72.69%	-42.14%
Return on Capital Employed (ROCE)	-6.70%	-16.10%	-19.50%	-45.50%	-68.80%	-46.90%
Earnings Yield	-0.92%	-4.43%	-11.88%	-18.88%	-17.27%	-20.22%
FCF Yield	0.98%	0.47%	-5.16%	-16.76%	-27.31%	-17.48%
Buyback Yield / Dilution	-4.69%	-16.23%	-20.31%	-12.07%	-20.08%	-119.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.